Demis Hassabis on Building DeepMind, AlphaFold, and the Final Stretch to AGI
From Training Data by Sequoia Capital
April 30, 2026 · 27 min
About this episode
Demis Hassabis discusses the path to AGI and the implications of AlphaFold in drug discovery.
Demis Hassabis, co-founder and CEO of Google DeepMind and 2024 Nobel laureate in chemistry for AlphaFold, joins Sequoia partner Konstantine Buhler at AI Ascent 2026 for a wide-ranging conversation about the path to AGI and what comes after. He explains why he believes AGI is achievable by 2030, why drug discovery could collapse from ten years to days, and why we should think of information, not matter or energy, as the most fundamental substance in the universe. Also: what Einstein would tell us about the limits of today's models, and why the next year or two will be critical for humanity.
People in this episode
Host: Konstantine Buhler
Guest: Demis Hassabis
Topics covered
- Artificial General Intelligence
- Drug Discovery
- AlphaFold
- DeepMind
- Future of Technology
- Scientific Innovation
Keywords
- AGI
- DeepMind
- AlphaFold
- Drug Discovery
- Einstein
- AI Ascent
- 2026
- Nobel Laureate
- Technology
Mentioned in this episode
Organizations: Google DeepMind
Books & works: AlphaFold
More episodes of Training Data
- Google DeepMind's Logan Kilpatrick: Why the Model Eats the Harness · June 11, 2026 · 51 min
- LIVE: Jensen Huang on Building the Dynamo of the Intelligence Age · June 10, 2026 · 41 min
- Knowing What Your Customers Want, All the Time: Listen Labs' Alfred Wahlforss · June 2, 2026 · 42 min
- How Cursor Trained Composer on Fireworks: Distributed Infrastructure for High-Performance RL · May 26, 2026 · 46 min
- Rebuilding IT From the Ground Up for the AI Age: Serval's Jake Stauch · May 19, 2026 · 38 min
- Suno's Mikey Shulman: Everyone Can Make Music Now · May 13, 2026 · 35 min
Explore listener stats, chart rankings, contacts and more on the Training Data podcast page.